Revs down, OPEX up, Forecast UP ranges $12.5 to $14.5 million. Loss flat due to dilution.
COMMENT: a high side beat on Revs next Quarter would make a dramatic swing in results, especially depending on OPEX R&D line containment.
Key Metrics
Q1 2018 Q4 2017 Q1 2017
Operating loss (7.3 ) (5.6 ) (4.2 )
Net loss (8.7 ) (7.6 ) (5.6 )
Revenue :
Product revenue $7,635 $8,685 $9,640
Other revenue 3,599 2,632 2,790
Total revenue 11,234 11,317 12,43
Operating expenses :
Research &development 7,519 5,985
Sales and marketing 2,485 2,203
General &administrative 1,971 2,159
Total OPEX 11,975 10,347 10,101
Current assets
Inventories 7,368 7,376
Trade receivables 17,535 20,826
Prepaid expenses and
other receivables 3,223 4,214
Research tax
credit receivable 4,230 3,248
Cash and
cash equivalents 14,638 2,948
Total current assets 48,236 39,647
Net cash flow used in
operating activities (6,009 ) (9,911 ) |
